Search

Search Constraints

You searched for: Author/Creator Leis, Jose F.

Search Results

31. Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia. Issue 2 (3rd July 2012)

34. Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice. Issue 11 (19th September 2019)

35. Single dose versus multiple doses of rituximab for preemptive therapy of Epstein–Barr virus reactivation after hematopoietic cell transplantation. Issue 1 (2nd January 2019)

36. The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice. (18th March 2020)

37. The prognostic significance of del6q23 in chronic lymphocytic leukemia. Issue 6 (7th April 2021)

38. Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: identifying risk factors to help guide treatment selection. Issue 2 (28th January 2023)

39. Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B‐cell lymphocytosis beyond the CLL international prognostic index. Issue 8 (7th May 2020)